Geron (GERN) Operating Leases (2019 - 2026)
Geron's (GERN) quarterly Operating Leases came in at $1.0 million in Q2 2026, down 46.38% year-over-year from $1.9 million in Q2 2025, and down 18.43% quarter-over-quarter from $1.2 million in Q1 2026.
Analysis
Geron (GERN) Operating Leases (2019 - 2026) Analysis & Trends
Geron has disclosed Operating Leases across 8 years of filings, most recently posting $1.0 million for Q2 2026.
- In Q2 2026, Operating Leases fell 46.38% year-over-year to $1.0 million; the TTM figure through Jun 2026 stood at $1.0 million (down 46.38% YoY), while the FY2025 annual figure was $1.4 million, down 36.23% from the prior year.
- Operating Leases came in at $1.0 million for Q2 2026 at Geron, down from $1.2 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $4.1 million in Q1 2022 to a low of $1.0 million in Q2 2026.
- Average Operating Leases over 5 years is $2.7 million, with a median of $2.7 million recorded in 2024.
- Year-over-year, Operating Leases decreased 11.71% in 2022 and slumped 46.38% in 2026.
- Over 5 years, Operating Leases stood at $3.7 million in 2022, then dropped by 18.11% to $3.0 million in 2023, then fell by 24.62% to $2.3 million in 2024, then plunged by 36.23% to $1.4 million in 2025, then sank by 30.8% to $1.0 million in 2026.
- Per Business Quant data, the three most recent Operating Leases figures were $1.0 million in Q2 2026, $1.2 million in Q1 2026, and $1.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 2.07 Mn |
| Dec 31, 2024 | 2.27 Mn |
| Sep 30, 2024 | 2.46 Mn |
| Jun 30, 2024 | 2.65 Mn |
| Mar 31, 2024 | 2.83 Mn |
| Dec 31, 2023 | 3.01 Mn |
| Sep 30, 2023 | 3.18 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 3.51 Mn |
| Dec 31, 2022 | 3.67 Mn |
| Sep 30, 2022 | 3.83 Mn |
| Jun 30, 2022 | 3.98 Mn |
| Mar 31, 2022 | 4.13 Mn |
| Dec 31, 2021 | 4.27 Mn |
| Sep 30, 2021 | 4.41 Mn |